TGFB1 and ovarian carcinoma: In malignancies, including ovarian cancer, TGF-β is a potent immunosuppressor within the tumor microenvironment, affecting natural killer and dendritic cell activity, cytokine production, and T-cell function [76,78,79,80,81].